News
NICE backs Roche's non-Hodgkin lymphoma drug Columvi
NICE backs NHS use of Roche's Columvi as a second-line therapy for a form of non-Hodgkin lymphoma affecting thousands of people in the UK each year.
News
AbbVie exits alliance with Alphabet biotech Calico; report
Reports are emerging that a multibillion-dollar partnership between AbbVie and Calico has come to an end after more than a decade.
News
FDA appoints veteran Pazdur to replace Tidmarsh
The FDA has steadied the ship at CDER by naming veteran regulator Richard Pazdur as director, although he was reportedly reluctant to take the job.
News
Trial sets up filing for enGene bladder cancer gene therapy
enGene is hoping to file its gene for a form of bladder cancer before the end of 2026, based on phase 2 data revealing a 62% complete response rate.
News
Daiichi Sankyo launches its STING operation against cancer
Daiichi Sankyo has started clinical testing of a STING agonist for cancer, a class that has been hit by safety issues and discontinued programmes.
News
Views & Analysis
Deep Dive
Editor's Picks
Editor's Picks
